Atai Life Sciences Total Liabilities 2020-2024 | ATAI

Atai Life Sciences total liabilities from 2020 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Atai Life Sciences Annual Total Liabilities
(Millions of US $)
2023 $49
2022 $40
2021 $28
2020 $16
2019 $2
Atai Life Sciences Quarterly Total Liabilities
(Millions of US $)
2024-03-31 $46
2023-12-31 $49
2023-09-30 $40
2023-06-30 $38
2023-03-31 $40
2022-12-31 $40
2022-09-30 $47
2022-06-30 $29
2022-03-31 $29
2021-12-31 $28
2021-09-30 $21
2021-06-30 $21
2021-03-31 $25
2020-12-31 $16
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $2
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.224B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.911B 0.00
Quest Diagnostics (DGX) United States $15.437B 15.95
DaVita (DVA) United States $12.399B 15.40
Elanco Animal Health (ELAN) United States $8.920B 23.14
Encompass Health (EHC) United States $8.544B 21.87
Chemed (CHE) United States $8.213B 25.46
Option Care Health (OPCH) United States $4.898B 18.54
RadNet (RDNT) United States $4.340B 90.37
Amedisys (AMED) United States $2.999B 21.24
Astrana Health (ASTH) United States $2.312B 31.26
LifeStance Health (LFST) United States $2.022B 0.00
Addus HomeCare (ADUS) United States $1.939B 27.74
U.S Physical Therapy (USPH) United States $1.388B 37.15
Pennant (PNTG) United States $0.677B 35.75
Aveanna Healthcare Holdings (AVAH) United States $0.492B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Novo Integrated Sciences (NVOS) United States $0.016B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00